Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

Background Prior economic analysis that compared the 12-gene assay to published patterns of care predicted the assay would improve outcomes while lowering medical costs for stage II, T3, mismatch-repair-proficient (MMR-P) colon cancer patients. This study assessed the validity of those findings with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	PharmacoEconomics 2014, Vol.32 (12), p.1231
Hauptverfasser:	Alberts, Steven R, Yu, Tiffany M, Behrens, Robert J, Renfro, Lindsay A, Srivastava, Geetika, Soori, Gamini S, Dakhil, Shaker R
Format:	Report
Sprache:	eng
Schlagworte:	Adjuvant treatment Analysis Cancer Care and treatment Colon cancer Diagnosis Medical care, Cost of Methods Relapse Tumor staging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!